Quarterly Results

CHEMO-PHARMA LABORATORIES LTD.

NSE : NABSE : 506365ISIN CODE : INE320M01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE65.001.72 (+2.72 %)
PREV CLOSE ( ) 63.28
OPEN PRICE ( ) 66.44
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1156
TODAY'S LOW / HIGH ( )65.00 66.44
52 WK LOW / HIGH ( ) 27.1784.6
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
NA
NA
NA
NA
Total Expenditure
0.23
0.18
0.51
0.2
PBIDT (Excl OI)
-0.23
-0.18
-0.51
-0.2
Other Income
7.02
4.6
4.29
-0.97
Operating Profit
6.79
4.42
3.78
-1.17
Interest
NA
NA
NA
NA
Exceptional Items
NA
NA
NA
NA
PBDT
6.79
4.42
3.78
-1.17
Depreciation
0.02
0.02
0.02
0.03
Profit Before Tax
6.77
4.4
3.76
-1.2
Tax
0.00
NA
NA
0.28
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
6.77
4.4
3.76
-1.48
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
6.77
4.4
3.76
-1.48
Equity Capital
15
15
15
15
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
4.51
2.93
2.50
-0.98
Calculated EPS (Annualised)
18.05
11.73
10.02
-3.94
No of Public Share Holdings
1081719
1081719
1081719
1081719
% of Public Share Holdings
72.11
72.11
72.11
72.11
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
NA
NA
NA
PBIDTM%
NA
NA
NA
NA
PBDTM%
NA
NA
NA
NA
PBTM%
NA
NA
NA
NA
PATM%
NA
NA
NA
NA
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.